{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:15:06Z","timestamp":1769969706876,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biologicals.2020.07.008","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T07:45:50Z","timestamp":1598255150000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of change in cell substrate on the critical quality attributes of L-Zagreb Mumps vaccine manufactured using parallel plate bioreactor"],"prefix":"10.1016","volume":"67","author":[{"given":"Ravindra","family":"Muley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Dhere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biologicals.2020.07.008_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-1157(89)90031-0","article-title":"Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials","volume":"17","author":"Beck","year":"1989","journal-title":"J Biol Stand"},{"issue":"1","key":"10.1016\/j.biologicals.2020.07.008_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2004.11.013","article-title":"Genetic characterization of L-Zagreb mumps vaccine strain","volume":"109","author":"Ivancic","year":"2005","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.biologicals.2020.07.008_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-422X-5-79","article-title":"Genetic heterogeneity of L-Zagreb mumps virus vaccine strain","volume":"5","author":"Kosutic-Gulija","year":"2008","journal-title":"Virol J"},{"issue":"12","key":"10.1016\/j.biologicals.2020.07.008_bib4","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s13312-018-1444-8","article-title":"Indian academy of pediatrics (IAP) advisory committee on vaccines and immunization practices (ACVIP) recommended immunization schedule (2018-19) and update on immunization for children aged 0 through 18 years","volume":"55","author":"Balasubramanian","year":"2018","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.biologicals.2020.07.008_bib5","author":"Food and Drug Administration"},{"key":"10.1016\/j.biologicals.2020.07.008_bib6","series-title":"Environmental monitoring of clean rooms in vaccine manufacturing facilities","author":"World Health Organization","year":"2012"},{"issue":"4","key":"10.1016\/j.biologicals.2020.07.008_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.5958\/0976-5506.2017.00400.4","article-title":"Towards next generation of live attenuated viral vaccines","volume":"8","author":"Muley","year":"2017","journal-title":"Indian J Publ Health Res Dev"},{"issue":"35","key":"10.1016\/j.biologicals.2020.07.008_bib8","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1016\/j.vaccine.2015.03.077","article-title":"An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures","volume":"33","author":"Pereira","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biologicals.2020.07.008_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/14760584.2017.1294068","article-title":"Development of a new purified Vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd","volume":"16","author":"Kulkarni","year":"2017","journal-title":"Expet Rev Vaccine"},{"issue":"22","key":"10.1016\/j.biologicals.2020.07.008_bib10","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.vaccine.2017.04.025","article-title":"Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL\u00ae)","volume":"35","author":"Naik","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2020.07.008_bib11","series-title":"Reducing risks with a serum-free medium for MRC-5 based vaccine production","author":"Hachmann","year":"2018"},{"issue":"2","key":"10.1016\/j.biologicals.2020.07.008_bib12","first-page":"26136","article-title":"Use of recombinant trypsin in production of vaccine against measles and rubella","volume":"8","author":"Vaidya","year":"2016","journal-title":"J Curr Res"},{"issue":"1","key":"10.1016\/j.biologicals.2020.07.008_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/gt.2017.91","article-title":"Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor","volume":"25","author":"Valkama","year":"2018","journal-title":"Gene Ther"},{"key":"10.1016\/j.biologicals.2020.07.008_bib14","series-title":"Control and scale-up of a microcarrier-based viral vaccine process using BioPAT\u00ae ViaMass for inline viable cell density measurement","author":"Juanola","year":"2020"},{"key":"10.1016\/j.biologicals.2020.07.008_bib15","series-title":"Case study: single-use platform for complete process development and scale-up of an Adenovirus","author":"Legmann","year":"2018"},{"key":"10.1016\/j.biologicals.2020.07.008_bib16","unstructured":"Dorceus, Michelet. \"Cell culture scale-up in stirred-tank single-use bioreactors.\" Bioproc Int 16, no. 11-12."},{"key":"10.1016\/j.biologicals.2020.07.008_bib17","series-title":"Continuous process performance enhancements for 50 L to 500 L single-use bioreactors: a technical comparison of performance characterization, cell culture, and scale-up modeling","author":"Hsiao","year":"2019"},{"issue":"5","key":"10.1016\/j.biologicals.2020.07.008_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.5958\/0976-5506.2018.00496.5","article-title":"Evaluation of a novel dynamic bed bioreactor for cultivation of mammalian cells","volume":"9","author":"Ravindra Ganpat","year":"2018","journal-title":"Indian J Publ Health Res Dev"},{"issue":"4","key":"10.1016\/j.biologicals.2020.07.008_bib19","first-page":"532","article-title":"Preliminary assessment of adaptability of Leningrad-Zagreb Mumps vaccine virus to human diploid cells and Vero cells","volume":"8","author":"Muley","year":"2017","journal-title":"Int J Pharm Bio Sci Volume"},{"issue":"2","key":"10.1016\/j.biologicals.2020.07.008_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"Ramakrishnan","year":"2016","journal-title":"World J Virol"},{"issue":"1","key":"10.1016\/j.biologicals.2020.07.008_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1743-422X-5-20","article-title":"Development and evaluation of one step single tube multiplex RT-PCR for rapid detection and typing of dengue viruses","volume":"5","author":"Saxena","year":"2008","journal-title":"Virol J"},{"issue":"271","key":"10.1016\/j.biologicals.2020.07.008_bib22","first-page":"2","article-title":"Single base primer extension assay SNaPShot for rapid detection of human immunodeficiency virus-1 drug resistance mutations","volume":"7","author":"Arpan","year":"2016","journal-title":"J Mol Biomarkers Diagn"},{"key":"10.1016\/j.biologicals.2020.07.008_bib23","series-title":"Q8 (R2) Current Step 4","article-title":"Pharmaceutical development","author":"Guideline","year":"2009"},{"key":"10.1016\/j.biologicals.2020.07.008_bib24","series-title":"WHO expert committee on biological standardization","article-title":"Requirements for measles, mumps and rubella vaccines and combined vaccines (live) (requirements for biological substance no. 47)","author":"World Health Organization","year":"1994"},{"issue":"1","key":"10.1016\/j.biologicals.2020.07.008_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3345\/kjp.2016.59.1.24","article-title":"Factors associated with mumps meningitis and the possible impact of vaccination","volume":"59","author":"Rhie","year":"2016","journal-title":"Korean J Pediatr"},{"issue":"11","key":"10.1016\/j.biologicals.2020.07.008_bib26","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1086\/591196","article-title":"Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?","volume":"47","author":"Dayan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2020.07.008_bib27","first-page":"29","article-title":"Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells","volume":"65","author":"Gl\u00fcck","year":"1986","journal-title":"Dev Biol Stand"},{"issue":"3","key":"10.1016\/j.biologicals.2020.07.008_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00365549609027163","article-title":"An outbreak of mumps in a population partially vaccinated with the Rubini strain","volume":"28","author":"Germann","year":"1996","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.biologicals.2020.07.008_bib29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jinf.2004.10.001","article-title":"Comparative efficacy of Rubini, jeryl\u2013lynn and Urabe mumps vaccine in an asian population","volume":"51","author":"Ong","year":"2005","journal-title":"J Infect"},{"issue":"9187","key":"10.1016\/j.biologicals.2020.07.008_bib30","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(99)02853-6","article-title":"Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain","volume":"354","author":"Goh","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biologicals.2020.07.008_bib31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/jmv.21087","article-title":"Genetic characterization of RS\u201012 (S\u201012), an Iranian isolate of mumps virus, by sequence analysis and comparative genomics of F, SH, and HN genes","volume":"80","author":"Alirezaie","year":"2008","journal-title":"J Med Virol"},{"key":"10.1016\/j.biologicals.2020.07.008_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jviromet.2013.12.020","article-title":"Evaluation of the thermal stability of a novel strain of live-attenuated mumps vaccine (RS-12 strain) lyophilized in different stabilizers","volume":"199","author":"Jamil","year":"2014","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.biologicals.2020.07.008_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/viro.2001.1009","article-title":"Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain","volume":"287","author":"Amexis","year":"2001","journal-title":"Virology"},{"issue":"36","key":"10.1016\/j.biologicals.2020.07.008_bib34","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.vaccine.2015.06.109","article-title":"In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine","volume":"33","author":"Connaughton","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biologicals.2020.07.008_bib35","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1099\/0022-1317-74-5-917","article-title":"The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates","volume":"74","author":"Afzal","year":"1993","journal-title":"J Gen Virol"},{"issue":"12","key":"10.1016\/j.biologicals.2020.07.008_bib36","doi-asserted-by":"crossref","first-page":"969","DOI":"10.47102\/annals-acadmedsg.V36N12p969","article-title":"Safety, reactogenicity and immunogenicity of the live attenuated combined measles, mumps and rubella vaccine containing the RIT 4385 mumps strain in healthy Singaporean children","volume":"36","author":"Lim","year":"2007","journal-title":"Ann Acad Med Singapore"},{"issue":"3","key":"10.1016\/j.biologicals.2020.07.008_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s15010-001-1098-7","article-title":"Neutralization activity and persistence of antibodies induced in response to vaccination with a novel mumps strain, RIT 4385","volume":"29","author":"Usonis","year":"2001","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.biologicals.2020.07.008_bib38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.micinf.2014.11.006","article-title":"Accumulation of defective interfering viral particles in only a few passages in Vero cells attenuates mumps virus neurovirulence","volume":"17","author":"\u0160antak","year":"2015","journal-title":"Microb Infect"},{"issue":"1","key":"10.1016\/j.biologicals.2020.07.008_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2006.01.035","article-title":"Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity","volume":"350","author":"Sauder","year":"2006","journal-title":"Virology"},{"issue":"45","key":"10.1016\/j.biologicals.2020.07.008_bib40","first-page":"346","article-title":"Mumps virus vaccines","volume":"76","author":"World Health Organization","year":"2001","journal-title":"Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.biologicals.2020.07.008_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1126\/scitranslmed.aao5945","article-title":"Vaccine waning and mumps re-emergence in the United States","volume":"10","author":"Lewnard","year":"2018","journal-title":"Sci Transl Med"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105620300889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105620300889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:30Z","timestamp":1760922870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105620300889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"alternative-id":["S1045105620300889"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.07.008","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of change in cell substrate on the critical quality attributes of L-Zagreb Mumps vaccine manufactured using parallel plate bioreactor","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}